Serum, Pleural Effusion, and Ascites CA-125 Levels in Ovarian Cancer and Nonovarian Benign and Malignant Diseases: A Comparative Study

By Topalak O.   Saygili U.   Soyturk M.   Karaca N.   Batur Y.   Uslu T.   Erten O.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 108-113

Elsevier

Access to resources Recommend Favorite

Effects of Paclitaxel on CA-125 Serum Levels in Ovarian Cancer Patients

By Paulsen T.   Marth C.   Kaern J.   Nustad K.   Kristensen G.B.   Trope C.  

Gynecologic Oncology, Vol. 76, Iss. 3, 2000-03 ,pp. : 326-330

Elsevier

Access to resources Recommend Favorite

The Relationship between Postoperative Decline of Serum CA 125 Levels and Size of Residual Disease after Initial Surgery in Patients with Advanced Ovarian Cancer: A CTF Study

By Gadducci A.   Landoni F.   Maggino T.   Sartori E.   Zola P.   Fanucchi A.  

Gynecologic Oncology, Vol. 63, Iss. 2, 1996-11 ,pp. : 234-237

Academic Press

Access to resources Recommend Favorite

Can Serum CA-125 Levels Predict the Optimal Primary Cytoreduction in Patients with Advanced Ovarian Carcinoma?

By Saygili U.   Guclu S.   Uslu T.   Erten O.   Demir N.   Onvural A.  

Gynecologic Oncology, Vol. 86, Iss. 1, 2002-07 ,pp. : 57-61

Academic Press

Access to resources Recommend Favorite

Predictive and Prognostic Values of Cancer-Associated Serum Antigen (CASA) and Cancer Antigen 125 (CA 125) Levels Prior to Second-Look Laparotomy for Ovarian Cancer

By Kierkegaard O.   Mogensen O.   Mogensen B.   Jakobsen A.  

Gynecologic Oncology, Vol. 59, Iss. 2, 1995-11 ,pp. : 251-254

Academic Press

Access to resources Recommend Favorite